imiglucerase

noun

im·​i·​glu·​ce·​rase ˌim-ə-ˈglü-sə-ˌrās 

: modified human glucocerebrosidase produced by recombinant DNA technology and administered by injection for enzyme replacement therapy in the treatment of Gaucher's disease

Imiglucerase has now been given to more than 5000 patients worldwide and clearly reverses many of the manifestations of Gaucher disease, particularly those affecting the bone marrow and viscera.

—Timothy M. Cox, Biologics: Targets & Therapies

Note: Imiglucerase is marketed under the trademark Cerezyme.